NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

肛門及大腸直腸癌的全球市場預測(2020年∼2026年)

Global Anal & Colorectal Cancer Market 2020-2026

出版商 Orion Market Research Pvt Ltd 商品編碼 1008084
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
肛門及大腸直腸癌的全球市場預測(2020年∼2026年) Global Anal & Colorectal Cancer Market 2020-2026
出版日期: 2021年04月23日內容資訊: 英文
簡介

全球肛門及大腸直腸癌的市場規模,預計以相當的年複合成長率擴大。大腸直腸癌是一種惡性腫瘤,來源於結腸或直腸的細胞,而在肛門癌的情況下是發生在肛門中。由於肥胖和煙草消費等不良生活方式,肛門癌和大腸直腸癌的患病率不斷上升,而產生了對其治療的需求,這推動了市場成長。大腸直腸癌是全球第三大常見惡性腫瘤,也是全球癌症相關死亡的第四大原因。

但,這個類型的癌症的認識低,肛門及大腸直腸癌症治療的高成本,成為市場成長的主要限制。

本報告提供全球肛門及大腸直腸癌市場相關調查分析,市場概要,市場決策要素,市場區隔,競爭情形,各地區分析,主要企業等相關的系統性資訊。

目錄

第1章 報告概要

第2章 市場概要與洞察

  • 調查範圍
  • 分析師的洞察和目前市場趨勢

第3章 競爭情形

  • 主要企業分析
    • 概要
    • 財務分析
    • SWOT分析
    • 最新趨勢
  • 主要的策略分析

第4章 市場決策要素

  • 成長要素
  • 阻礙因素
  • 市場機會

第5章 市場區隔

  • 各治療類型市場
    • 放射治療
    • 化療
    • 標靶治療
    • 免疫療法
  • 各終端用戶市場
    • 醫院
    • 門診病人手術中心
    • 癌症調查中心

第6章 地區分析

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 法國
    • 其他歐洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他亞太地區
  • 其他地區

第7章 企業簡介

  • Advaxis, Inc.
  • Amgen Inc.
  • Atara Biotherapeutics, Inc.
  • Bayer AG
  • Beckman Coulter, Inc.
  • Boehringer Ingelheim International GmbH
  • Clinical Genomics Technologies Pvt. Ltd.
  • EDP Biotech Corp.
  • Eli Lilly and Co.
  • Exact Sciences Corp.
  • Genomictree Co., Ltd.
  • IMV Inc.
  • ISA Pharmaceuticals B.V.
  • Merck & Co., Inc.
  • Metabiomics Corp.
  • 小野藥品工業
  • ORYX GmbH & Co. KG,
  • Quest Diagnostics Inc.,
  • Randox Laboratories Ltd.
  • F. Hoffmann-La Roche Ltd.
  • Siemens AG
  • 大鵬藥品工業
  • Taiwan Liposome Co, Ltd.
  • VolitionRX Ltd.
目錄
Product Code: OMR2023377

Global Anal & Colorectal Cancer Market Size, Share & Trends Analysis Report by Treatment (Radiation Therapy, Chemotherapy, Targeted Therapy, and Immunotherapy), By End-User (Hospitals, Ambulatory Surgery Centers, and Cancer Research Centers) Forecast Period 2020-2026

The global anal & colorectal cancer market is anticipated to grow at a considerable CAGR during the forecast period. Colorectal cancer is a malignant tumor that starts in the cells of the colon or the rectum while it takes place in the anus in case of anal cancer. The rising prevalence of anal and colorectal cancer due to poor lifestyles such as obesity and tobacco consumption has created a demand for its treatment which, in turn, is driving the market growth. Colorectal cancer is the third most common malignancy and the fourth leading cause of cancer-related mortalities globally. As per the World Health Organization (WHO), in 2020, the number of colorectum cancer of mortality of male and female of all ages was around 935,173 across the globe, which is 9.4% of total mortalities. Additionally, the number of new colorectum cancer patients of both sexes of all ages in 2020 was around 1.9 million globally, which is 10.0% of new cancer cases.

As per the American Cancer Society, around 9,090 new cases of anal cancer are expected in the US in 2021, of which 6,070 in women and 3,020 in men. Besides, around 1,430 mortalities of anal cancer are expected in 2021. Apart from it, around 104,270 new cases of colon cancer and around 45,230 new cases of rectal cancer are expected in the US in 2021. Furthermore, the increasing geriatric population which is more prone to colorectal cancer is another factor driving the market growth. However, the high cost of anal and colorectal cancer treatment along with low awareness towards this type of cancer act as major restraints for the market growth. However, increasing healthcare expenditure, technological advancement for cancer treatment, and rising demand for anal and colorectal cancer treatment are expected to drive the market especially in developing countries.

Segmental Outlook

The global anal and colorectal cancer market is segmented based on treatment and end-user. Based on the treatment, the market is segmented into radiation therapy, chemotherapy, targeted therapy, and immunotherapy. Based on end-users the market is segmented into hospitals, ambulatory surgery centers, and cancer research centers. Hospitals held a major market share in 2019 based on end-user. The factors such as rising quality assessment in hospitals, growing colorectal cancer cases among individuals, and increasing demand for minimal complication rates in surgery of special colorectal cancer are anticipating driving the growth of this market segment.

Regional Outlooks

The global anal & colorectal cancer market is further segmented based on geography into North America, Europe, Asia-Pacific, and the Rest of the World. North America has been predicted to dominate the global anal & colorectal cancer market. The high prevalence of anal & colorectal cancer cases in the US along with easy access of US citizens to its treatment due to the presence of well-established healthcare infrastructure is anticipated to drive the growth of this regional growth of market.

Global Anal & Colorectal Cancer Market Growth by Region, 2020-2026

Source: OMR Global

Asia-Pacific is Projected to Exhibit Considerable Growth in the Global Anal & Colorectal Cancer Market

Asia-Pacific is anticipated to exhibit considerable growth in the global anal & colorectal cancer market during the forecast period. The rising geriatric population which is prone to cancer coupled with the increasing incidence and prevalence rate of anal & colorectal cancer are the factors driving the regional growth of the market. As per the WHO, in 2020, in Asia-pacific, around 569,186 incidences of colon cancer were recorded, which is 49.6% of total cases across the globe. Besides, around 296,236 mortalities were recorded due to colon cancer in 2020, which was around 51.4%. Apart from this, the number of anal cancer patients in 2020 was 16,645, and mortalities were 8,120 in the region.

Market Players Outlook

Some of the key players of the anal & colorectal cancer market include Amgen Inc., Taiho Pharmaceutical Co., Ltd, F. Hoffmann-La Roche Ltd, Quest Diagnostics Inc., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers & acquisitions, collaborations, funding, and new product launches, to stay competitive in the market.

The Report Covers

  • Market value data analysis of 2019 and forecast to 2026.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global anal and colorectal cancer market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
    • 3.1.1. Overview
    • 3.1.2. Financial Analysis
    • 3.1.3. SWOT Analysis
    • 3.1.4. Recent Developments
  • 3.2. Key Strategy Analysis

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global ANAL & COLORECTAL Cancer Market by Treatment Type
    • 5.1.1. Radiation Therapy
    • 5.1.2. Chemotherapy
    • 5.1.3. Targeted Therapy
    • 5.1.4. Immunotherapy
  • 5.2. Global ANAL & COLORECTAL Cancer Market by End-User
    • 5.2.1. Hospitals
    • 5.2.2. Ambulatory Surgery Centers
    • 5.2.3. Cancer Research Centers

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. South Korea
    • 6.3.5. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. Advaxis, Inc.
  • 7.2. Amgen Inc.
  • 7.3. Atara Biotherapeutics, Inc.
  • 7.4. Bayer AG
  • 7.5. Beckman Coulter, Inc.
  • 7.6. Boehringer Ingelheim International GmbH
  • 7.7. Clinical Genomics Technologies Pvt. Ltd.
  • 7.8. EDP Biotech Corp.
  • 7.9. Eli Lilly and Co.
  • 7.10. Exact Sciences Corp.
  • 7.11. Genomictree Co., Ltd.
  • 7.12. IMV Inc.
  • 7.13. ISA Pharmaceuticals B.V.
  • 7.14. Merck & Co., Inc.
  • 7.15. Metabiomics Corp.
  • 7.16. ONO Pharmaceutical Co., Ltd.
  • 7.17. ORYX GmbH & Co. KG,
  • 7.18. Quest Diagnostics Inc.,
  • 7.19. Randox Laboratories Ltd.
  • 7.20. F. Hoffmann-La Roche Ltd.
  • 7.21. Siemens AG
  • 7.22. Taiho Pharmaceutical Co., Ltd.
  • 7.23. Taiwan Liposome Co, Ltd.
  • 7.24. VolitionRX Ltd.

LIST OF TABLES

  • 1. GLOBAL ANAL & COLORECTAL CANCER MARKET RESEARCH AND ANALYSIS BY TREATMENT TYPE, 2019-2026 ($ MILLION)
  • 2. GLOBAL RADIATION THERAPY FOR ANAL & COLORECTAL CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 3. GLOBAL CHEMOTHERAPY ANAL & COLORECTAL CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 4. AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
  • 5. GLOBAL TARGETED THERAPY ANAL & COLORECTAL CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 6. GLOBAL IMMUNOTHERAPY ANAL & COLORECTAL CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 7. GLOBAL ANAL & COLORECTAL CANCER MARKET RESEARCH AND ANALYSIS BY END-USER, 2019-2026 ($ MILLION)
  • 8. GLOBAL HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 9. GLOBAL AMBULATORY SURGERY CENTERS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 10. GLOBAL CANCER RESEARCH CENTERS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 11. GLOBAL ANAL & COLORECTAL CANCER MARKET RESEARCH AND ANALYSIS REGION, 2019-2026 ($ MILLION)
  • 12. NORTH AMERICAN ANAL & COLORECTAL CANCER MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
  • 13. NORTH AMERICAN ANAL & COLORECTAL CANCER MARKET RESEARCH AND ANALYSIS BY END-USER, 2019-2026 ($ MILLION)
  • 14. NORTH AMERICAN ANAL & COLORECTAL CANCER MARKET RESEARCH AND ANALYSIS BY TREATMENT TYPE, 2019-2026 ($ MILLION)
  • 15. EUROPEAN ANAL & COLORECTAL CANCER MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
  • 16. EUROPEAN ANAL & COLORECTAL CANCER MARKET RESEARCH AND ANALYSIS BY END-USER, 2019-2026 ($ MILLION)
  • 17. EUROPEAN ANAL & COLORECTAL CANCER MARKET RESEARCH AND ANALYSIS BY TREATMENT TYPE, 2019-2026 ($ MILLION)
  • 18. ASIA-PACIFIC ANAL & COLORECTAL CANCER MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
  • 19. ASIA-PACIFIC ANAL & COLORECTAL CANCER MARKET RESEARCH AND ANALYSIS BY END-USER, 2019-2026 ($ MILLION)
  • 20. ASIA-PACIFIC ANAL & COLORECTAL CANCER MARKET RESEARCH AND ANALYSIS BY TREATMENT TYPE, 2019-2026 ($ MILLION)
  • 21. REST OF THE WORLD ANAL & COLORECTAL CANCER MARKET RESEARCH AND ANALYSIS BY END-USER, 2019-2026 ($ MILLION)
  • 22. REST OF THE WORLD ANAL & COLORECTAL CANCER MARKET RESEARCH AND ANALYSIS BY TREATMENT TYPE, 2019-2026 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL ANAL & COLORECTAL CANCER MARKET SHARE BY END-USER, 2019 VS 2026 (%)
  • 2. GLOBAL ANAL & COLORECTAL CANCER MARKET SHARE BY TREATMENT TYPE, 2019 VS 2026 (%)
  • 3. GLOBAL ANAL & COLORECTAL CANCER MARKET SHARE BY GEOGRAPHY, 2019 VS 2026 (%)
  • 4. GLOBAL RADIATION THERAPY FOR ANAL & COLORECTAL MARKET SHARE BY REGION, 2019 VS 2026 (%)
  • 5. GLOBAL CHEMOTHERAPY IN ANAL & COLORECTAL MARKET SHARE BY REGION, 2019 VS 2026 (%)
  • 6. GLOBAL TARGETED THERAPY IN ANAL & COLORECTAL MARKET SHARE BY REGION, 2019 VS 2026 (%)
  • 7. GLOBAL IMMUNOTHERAPHY IN ANAL & COLORECTAL MARKET SHARE BY REGION, 2019 VS 2026 (%)
  • 8. GLOBAL HOSPITALS SEGMENT IN ANAL & COLORECTAL MARKET SHARE BY REGION, 2019 VS 2026 (%)
  • 9. GLOBAL AMBULATORY SURGERY CENTRES SEGMENT IN ANAL & COLORECTAL MARKET SHARE BY REGION, 2019 VS 2026 (%)
  • 10. GLOBAL CANCER RESEARCH CENTERS IN ANAL & COLORECTAL MARKET SHARE BY REGION, 2019 VS 2026 (%)
  • 11. US ANAL & COLORECTAL CANCER MARKET SIZE, 2019-2026 ($ MILLION)
  • 12. CANADA ANAL & COLORECTAL CANCER MARKET SIZE, 2019-2026 ($ MILLION)
  • 13. UK ANAL & COLORECTAL CANCER MARKET SIZE, 2019-2026 ($ MILLION)
  • 14. FRANCE ANAL & COLORECTAL CANCER MARKET SIZE, 2019-2026 ($ MILLION)
  • 15. GERMANY ANAL & COLORECTAL CANCER MARKET SIZE, 2019-2026 ($ MILLION)
  • 16. ITALY ANAL & COLORECTAL CANCER MARKET SIZE, 2019-2026 ($ MILLION)
  • 17. SPAIN ANAL & COLORECTAL CANCER MARKET SIZE, 2019-2026 ($ MILLION)
  • 18. REST OF EUROPE ANAL & COLORECTAL CANCER MARKET SIZE, 2019-2026 ($ MILLION)
  • 19. INDIA ANAL & COLORECTAL CANCER MARKET SIZE, 2019-2026 ($ MILLION)
  • 20. CHINA ANAL & COLORECTAL CANCER MARKET SIZE, 2019-2026 ($ MILLION)
  • 21. JAPAN ANAL & COLORECTAL CANCER MARKET SIZE, 2019-2026 ($ MILLION)
  • 22. SOUTH KOREA ANAL & COLORECTAL CANCER MARKET SIZE, 2019-2026 ($ MILLION)
  • 23. REST OF ASIA-PACIFIC ANAL & COLORECTAL CANCER MARKET SIZE, 2019-2026 ($ MILLION)
  • 24. REST OF THE WORLD ANAL & COLORECTAL CANCER MARKET SIZE, 2019-2026 ($ MILLION)